1887
  1. Home
  2. BSAVA Small Animal Formulary Part A: Canine and Feline
  3. S-Adenosylmethionine (SAMe)
S-Adenosylmethionine (SAMe)
; https://doi.org/
/content/dataitem/canine-and-feline/s-adenosylmethionine

S-Adenosylmethionine (SAMe)

Online Access: Subscribe
This is a drug monograph from the BSAVA Small Animal Formulary Part A: Canine and Feline. BSAVA members should login for access to the full monograph. Non-members can join BSAVA, buy a Formulary subscription, or buy the printed edition. 
  1. Au AY, Hasenwinkel JM and Frondoza CG (2013) Hepatoprotective effects of S-adenosylmethionine and silybin on canine hepatocytes in vitro. Journal of Animal Physiology and Animal Nutrition (Berl) 97, 331–341
    2.
  2. Center SA, Randolph JF, Warner KL et al. (2005) The effects of S-adenosylmethionine on clinical pathology and redox potential in the red blood cell, liver, and bile of clinically normal cats. Journal of Veterinary Internal Medicine 19, 303–314
    3.
  3. Center SA, Warner KL, McCabe J et al. (2005) Evaluation of the influence of S-adenosylmethionine on systemic and hepatic effects of prednisolone in dogs. American Journal of Veterinary Research 66, 330–341
    4.
  4. Hagen DM, Ekena JL, Geesaman BM and Viviano KR (2019) Antioxidant supplementation during illness in dogs: effect on oxidative stress and outcome, an exploratory study. Journal of Small Animal Practice 60, 543–550
    5.
  5. Imhoff DJ, Gordon-Evans WJ, Evans RB et al. (2011) Evaluation of S-adenosyl l-methionine in a double-blinded, randomized, placebo-controlled, clinical trial for treatment of presumptive osteoarthritis in the dog. Veterinary Surgery 40, 228–232
    6.
  6. Reme CA, Dramard V, Kern L et al. (2008) Effect of S-adenosylmethionine tablets on the reduction of age-related mental decline in dogs: a double-blinded, placebo-controlled trial. Veterinary Therapeutics 9, 69–82
    7.
  7. Skorupski KA, Hammond GM, Irish AM et al. (2011) Prospective randomized clinical trial assessing the efficacy of Denamarin for prevention of CCNU-induced hepatopathy in tumor-bearing dogs. Journal of Veterinary Internal Medicine 25, 838–845
    8.
  8. Vandeweerd JM, Cambier C and Gustin P (2013) Nutraceuticals for canine liver disease: assessing the evidence. Veterinary Clinics of North America: Small Animal Practice 43, 1171–1179
    9.
  9. Wallace KP, Center SA, Hickford FH, Warner KL and Smith S (2002) S-adenosyl-L-methionine (SAMe) for the treatment of acetaminophen toxicity in a dog. Journal of the American Animal Hospital Association 38, 246–254
    10.
  10. Webb CB, Twedt DC, Fettman MJ and Mason G (2003) S-adenosylmethionine (SAMe) in a feline acetaminophen model of oxidative injury. Journal of Feline Medicine and Surgery 5, 69–75
    11.
  11. Webster CR and Cooper J (2009) Therapeutic use of cytoprotective agents in canine and feline hepatobiliary disease. Veterinary Clinics of North America: Small Animal Practice 39, 631–652
    12.
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error